HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H909. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,002 | +25.9% | 78,600 | +18.9% | 0.00% | 0.0% |
| Q2 2023 | $2,384 | -29.4% | 66,100 | -25.3% | 0.00% | -33.3% |
| Q1 2023 | $3,379 | +31.7% | 88,500 | +96.2% | 0.00% | 0.0% |
| Q4 2022 | $2,566 | -99.5% | 45,100 | +260.8% | 0.00% | +200.0% |
| Q3 2022 | $494,000 | +40.3% | 12,500 | +56.2% | 0.00% | – |
| Q2 2022 | $352,000 | +60.7% | 8,000 | +45.5% | 0.00% | – |
| Q1 2022 | $219,000 | -42.5% | 5,500 | -42.1% | 0.00% | – |
| Q4 2021 | $381,000 | -80.7% | 9,500 | -77.7% | 0.00% | -100.0% |
| Q3 2021 | $1,974,000 | +2.3% | 42,600 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $1,929,000 | – | 42,500 | +81630.8% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 52 | -7.1% | 0.00% | – |
| Q4 2020 | $239,000 | -69.8% | 56 | -81.4% | 0.00% | -100.0% |
| Q3 2020 | $791,000 | -75.7% | 301 | -75.2% | 0.00% | -80.0% |
| Q2 2020 | $3,254,000 | +199.1% | 1,214 | +100.7% | 0.01% | +150.0% |
| Q1 2020 | $1,088,000 | -59.3% | 605 | -59.8% | 0.00% | -66.7% |
| Q4 2019 | $2,670,000 | +378.5% | 1,506 | +318.3% | 0.01% | +200.0% |
| Q3 2019 | $558,000 | +62.7% | 360 | +80.0% | 0.00% | +100.0% |
| Q2 2019 | $343,000 | +111.7% | 200 | +98.0% | 0.00% | – |
| Q1 2019 | $162,000 | -12.4% | 101 | -20.5% | 0.00% | -100.0% |
| Q4 2018 | $185,000 | -71.0% | 127 | -63.9% | 0.00% | -50.0% |
| Q3 2018 | $639,000 | +579.8% | 352 | +528.6% | 0.00% | – |
| Q2 2018 | $94,000 | +571.4% | 56 | -54.8% | 0.00% | -100.0% |
| Q1 2018 | $14,000 | -83.5% | 124 | -18.4% | 0.00% | -75.0% |
| Q4 2017 | $85,000 | -66.8% | 152 | -82.5% | 0.00% | -60.0% |
| Q3 2017 | $256,000 | +158.6% | 871 | -30.9% | 0.01% | +150.0% |
| Q2 2017 | $99,000 | +28.6% | 1,260 | +41.4% | 0.00% | +33.3% |
| Q1 2017 | $77,000 | -55.7% | 891 | -47.2% | 0.00% | -70.0% |
| Q4 2016 | $174,000 | -28.7% | 1,687 | +71.1% | 0.01% | -41.2% |
| Q3 2016 | $244,000 | +201.2% | 986 | +39.7% | 0.02% | +240.0% |
| Q2 2016 | $81,000 | -49.4% | 706 | -15.6% | 0.01% | -61.5% |
| Q1 2016 | $160,000 | +50.9% | 836 | +143.0% | 0.01% | +62.5% |
| Q4 2015 | $106,000 | +341.7% | 344 | +240.6% | 0.01% | +300.0% |
| Q3 2015 | $24,000 | -72.4% | 101 | -32.7% | 0.00% | -71.4% |
| Q2 2015 | $87,000 | +148.6% | 150 | +24.0% | 0.01% | +75.0% |
| Q1 2015 | $35,000 | +400.0% | 121 | -18.2% | 0.00% | +300.0% |
| Q4 2014 | $7,000 | – | 148 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 27,600 | $1,101,000 | 0.00% |
| JPMORGAN CHASE & CO | 155,400 | $6,197,000 | 0.00% |
| SIMPLEX TRADING, LLC | 5,500 | $219,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |